Natalie Dayneka

Dr. Natalie Dayneka is a Canadian clinical paediatric pharmacist based in Ottawa, Ontario. She is notable during the COVID-19 pandemic due to her role in approving COVID-19 vaccines while serving on the National Advisory Committee on Immunization (NACI).¹⁾

Dayneka has worked as a pharmacist in several locations including Churchill, Manitoba, Philadelphia, and at SickKids in Toronto, Ontario.²⁾

She has published research on behalf of the Department of Pharmaceutics, School of Pharmacy at the State University of New York and the Philadelphia College of Pharmacy and Science.³⁾

Dayneka has played an active role developing pediatric guidelines for Infectious Diseases, including Immunizations.

Dayneka is a clinical specialist with the Pharmacy Department of the tertiary care pediatric teaching hospital Children's Hospital of Eastern Ontario (CHEO). She was a co-author of the online 2015 CHEO Antimicrobial Guidelines for Children which has been offered externally as a mobile application (APP) for pediatric practitioners across Canada.

She has consulted on various federal committees and was a member of the Pharmacology and Therapeutics Committee for the First Nations and Inuit Health Programs Directorate. She also served on the Canadian Paediatric Society's Drug Therapy and Hazardous Substances Committee. More recently, she served on the Ontario Quality Based Procedure Tonsillectomy Clinical Expert Advisory Group.

She has been very active with the Canadian Society of Hospital Pharmacists (CSHP) and was awarded the title of Fellow.

Dayneka has served as a member, Chair and Past Chair of the Canadian HIV/AIDS Pharmacists Network (CHAP) (now called the Canadian HIV and Viral Hepatitis Pharmacists Network),^{4) 5) 6)} where she published research sponsored by Merck.⁷⁾ Additional sponsors of the network during her membership include Abbott, AbbVie, Boehringer Ingelheim, Bristol-Myers Squibb, Gilead Sciences, Janssen, Theratechnologies, and ViiV Healthcare.⁸⁾ The network itself is sponsored by the Toronto General Hospital HIV Clinic, which is funded through unrestricted grants by AbbVie, Gilead Sciences and ViiV Healthcare.⁹⁾

Dayneka is employed by the Public Health Agency of Canada's Immunization Branch as a senior advisor in Causality Assessment for COVID-19 vaccine surveillance.^{10) 11)}

Dayneka formerly served on the National Advisory Committee on Immunization (NACI), including as chair of the Vaccine Safety Working Group.¹²⁾